Top Biotechnology & Medical Research stocks in United States

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconGILDGilead Sciences$78.22bn12.554.59%
us flag iconVRTXVertex Pharmaceuticals$73.48bn30.35n/a
us flag iconREGNRegeneron Pharmaceuticals$65.40bn8.41n/a
us flag iconMRNAModerna$59.64bn4.41n/a
us flag iconIQVIqvia Holdings$40.70bn38.18n/a
us flag iconBNTXBioNTech SE$38.20bn2.96n/a
us flag iconSGENSeagen$33.15bnn/an/a
us flag iconALNYAlnylam Pharmaceuticals$17.91bnn/an/a
us flag iconICLRICON$17.29bn45.7n/a
us flag iconTECHBIO-TECHNE$13.86bn63.330.36%
us flag iconCRLCharles River Laboratories International$11.12bn26.11n/a
us flag iconQGENQiagen NV$10.88bn19.74n/a
us flag iconUTHRUnited Therapeutics$10.78bn16.37n/a
us flag iconBHVNBiohaven Pharmaceutical Holding$10.32bnn/an/a
us flag iconNBIXNeurocrine Biosciences$9.49bn68.29n/a
us flag iconLEGNLegend Biotech$8.61bnn/an/a
us flag iconMRVIMaravai Lifesciences Holdings$7.50bn16.61n/a
us flag iconSYNHSyneos Health$7.34bn27.8n/a
us flag iconEXASExact Sciences$7.24bnn/an/a
us flag iconEXELExelixis$6.92bn23.38n/a